Developing new drugs that activate the protective arm of the renin–angiotensin system as a potential treatment for respiratory failure in COVID-19 patients

COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has reached pandemic proportions with negative impacts on global health, the world economy and human society. The clinical picture of COVID-19, and the fact that Angiotensin converting enzyme 2 (ACE2) is a receptor of...

Descripción completa

Detalles Bibliográficos
Autores principales: Latil, Mathilde, Camelo, Serge, Veillet, Stanislas, Lafont, René, Dilda, Pierre J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7888990/
https://www.ncbi.nlm.nih.gov/pubmed/33609783
http://dx.doi.org/10.1016/j.drudis.2021.02.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7888990/
https://www.ncbi.nlm.nih.gov/pubmed/33609783
http://dx.doi.org/10.1016/j.drudis.2021.02.010

Ejemplares similares